Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis
Technology and Health Care · 28.04.2023 · 31 · 357-372
DOI: 10.3233/thc-236031 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Technology and Health Care, erschienen am 28.04.2023. Verfasst von Xuanzhe Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hospital of Haicang, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Brachytherapy, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: 125I BT is an effective radiotherapy for prostate cancer. However, comparison data of GI and GU toxicities between BT, BT + EBRT, and EBRT-alone patient groups is limited. OBJECTIVE: To define the GI and GU toxicities in prostate cancer to prevent adverse events after treatment. METHODS: We searched published studies in PubMed, Cochrane, and Embase databases up to December 31, 2022. The endpoints were the RRs of GI and GU toxicities. Pooled data were assessed using a random-effects model. RESULTS: Fifteen eligible studies were included into this analysis. LDR-BT had significantly lower RRs than LDR-BT + EBRT for acute GI (2.13; 95% CI, 1.22–3.69; P= 0.007) and late GI toxicities (3.96; 95% CI, 1.23–12.70; P= 0.02). Moreover, EBRT had significantly higher RRs than LDR-BT for acute GU (2.32; 95% CI, 1.29–4.15; P= 0.005) and late GU toxicities (2.38; 95% CI, 1.27–4.44; P= 0.007). HDR-BT had significantly higher RRs for acute GU toxicities than LDR-BT alone (0.30; 95% CI, 0.23–0.40; P< 0.00001). CONCLUSION: The results implied that BT with and without EBRT can result in both GI and GU toxicities in patients with prostate cancer, with LDR-BT leading to a poorer urinary function than EBRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Hospital of Haicang, Xiamen, Fujian, China.
- Department of Anesthesiology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, Fujian, China.
- Department of Radiology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, Fujian, China.
- Department of Basic Medicine, Xiamen Medical College, Xiamen, Fujian, China.
Zitieren
APA
Li, X., Shan, L., Wang, Q., Zhai, H., Xuan, Y., & Yan, G. (2023). Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis. Technology and Health Care, 31, 357-372. https://doi.org/10.3233/thc-236031
Vancouver
Li X, Shan L, Wang Q, Zhai H, Xuan Y, Yan G. Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis. Technology and Health Care. 2023;31:357-372. doi:10.3233/thc-236031
BibTeX
@article{Li2023,
author = {Li, Xuanzhe and Shan, Ligang and Wang, Qianqi and Zhai, Huige and Xuan, Yinghua and Yan, Gen},
title = {Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis},
journal = {Technology and Health Care},
year = {2023},
volume = {31},
pages = {357--372},
doi = {10.3233/thc-236031}
}
EUVIMED